EODData

NASDAQ, PRME: Prime Medicine Inc

18 May 26 15:59
LAST:

2.815

CHANGE:
 0.12
OPEN:
3.070
HIGH:
3.100
ASK:
0.000
VOLUME:
3.19M
CHG(%):
4.10
PREV:
2.930
LOW:
2.750
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
18 May 262.9402.9802.7502.8103.71M
15 May 263.0803.0902.9302.9303.11M
14 May 263.3003.3503.1103.1302.24M
13 May 263.2503.3503.2303.2702.44M
12 May 263.2503.3603.1853.3003.06M
11 May 263.2003.5953.1853.2403.19M
08 May 263.2103.3953.0853.2102.45M
07 May 263.4103.5503.0603.1153.96M
06 May 263.4503.4853.2803.4102.7M
05 May 263.4903.5603.2803.3902.69M

PROFILE

Name:Prime Medicine Inc
About:Prime Medicine, Inc., a biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States. It offers Prime Editing technology comprising a programmable DNA binding domains, such as Cas domains, are typically modified such that they do not cause a double-stranded break in the DNA, as well as a RT domain that copies the edited DNA sequence directly into the target genomic site where the edit is made; and pegRNA which contains a search sequence, also known as a spacer, which provides a target genomic address for the Prime Editor. The company has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. Prime Medicine, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:60 First Street, Cambridge, MA, United States, 02141
Website:https://primemedicine.com
CUSIP:74168J101
CIK:0001894562
ISIN:US74168J1016
FIGI:BBG011RT3R55

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-2.76 
Forward P/E:-4.15 
PEG Ratio:0.25 
Price to Sales:177.52 
Price to Book:4.94 
Operating Margin:-47.87 
Return on Assets:-0.47 
Return on Equity:-1.55 
EPS Ratio:-1.35 
Revenue:4.96M 
Shares:180.55M 
Market Cap:508.25M 

TECHNICAL INDICATORS

MA5:3.099.7%
MA10:3.1813.0%
MA20:3.4221.5%
MA50:3.5425.6%
MA100:3.6830.8%
MA200:4.0142.5%
RSI14:19.44 
WPR14:-100.00 
MTM14:-0.72
ROC14:-0.20 
ATR:0.25 
Week High:3.6027.7%
Week Low:2.752.4%
Month High:4.0343.2%
Month Low:2.7542.5%
Year High:6.94146.5%
Year Low:1.11153.6%
Volatility:9.40